Skip to main content
Premium Trial:

Request an Annual Quote

Protein, DNA-Analysis Shop Deltadot Raises $10.4M in VC Round

NEW YORK, March 29 (GenomeWeb News) - Deltadot has raised £6 million ($10.4 million) in a round of venture capital financing, the company said today.


The company will use the cash to increase production capacity of its recently launched Peregrine and Merlin systems; develop an international sales and marketing force; and help the company develop a protein-folding/-unfolding chip for drug discovery and QA/QC applications, and a "virtual" 2D chip to "replace" 2D gels.


Major participants in the financing round included existing investors FF&P Private Equity Limited, which led the round; Imperial Innovations; and NPI Ventures; as well as new investors London Technology Fund and Sitka Health Fund.


Deltadot, based in London, develops and sells tools for protein and nucleic-acid analysis through the use of its Label Free Intrinsic Imaging technology, the company said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.